Drug Pricing Remains in Focus as Congress Questions Mylan, FDA

On September 21, 2016, the U.S. House Oversight and Government Reform Committee held a hearing to discuss the rising price of EpiPens. The two witnesses at this hearing were Heather Bresch, the Chief Executive Officer of Mylan, Inc., and Dr. Doug Throckmorton, the Deputy Director of the Center for Drug Evaluation and Research at the […]